Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
HF 2022: Heart Failure Highlights of 2022 with Prof Cleland
Author(s): John GF Cleland Added: 1 year ago
Prof John Cleland (University of Glasgow & Glasgow Royal Infirmary, Glasgow, UK) joined us to talk about heart failure management highlights in 2022 including a new phenotype, HFsnEF; available and new treatment options; news on SGLT2is and more. Recorded at Heart Failure 2022, Madrid. Videographer: Tom Green Editor: Mirjam Boros View more

Standards & Guidelines

Heart Failure
Implementing Heart Failure Guidelines with Collaborative Care
Start date: Aug 27, 2023 End date: Aug 27, 2023
Radcliffe Medical Education present a satellite symposium entitled ‘Implementing Heart Failure Guidelines with Collaborative Care’ at the ESC Congress 2023 in Amsterdam, NL. Join us in the Riga Lecture Room, or online, on Sunday 27 August 2023, from 12:45 to 13:45 CEST. This session, chaired by Prof Carolyn Lam (National Heart Centre Singapore, SG), provides an excellent opportunity for… View more

Heart Failure
Author(s): Christopher R deFilippi , G Michael Felker Added: 3 years ago
Biomarkers have become central to the management of cardiovascular disease, and their potential clinical applications continue to grow. This article reviews galectin-3 (Gal-3), a novel biomarker of fibrosis and remodeling, and its clinical application in heart failure (HF). Case Studies Case Study One A 63-year-old African-American female presents to the emergency department with acute dyspnea… View more

Heart Failure

MI/ACS
Author(s): Marco Guazzi Added: 3 years ago
Inhibitors of phosphodiesterase-5 (PDE5) are a class of drug that were originally developed as anti-ischaemic agents based on their ability to overexpress the nitric oxide (NO) pathway pursued via cyclic guanosine monophosphate (cGMP) signalling. Since the effects on myocardial oxygen consumption determinants were found to be less relevant than expected,1 they were not considered to have a real… View more

Heart Failure
SGLT-2 Inhibitors in Heart Failure: Putting the Evidence Into Practice
Author(s): Andrew JS Coats , Giuseppe Rosano Added: 2 years ago
Following the release at ESC 2021 of updated guidelines for the diagnosis and treatment of acute and chronic heart failure, Prof Andrew Coats (Monash University, Australia and University of Warwick, UK) and Prof Giuseppe Rosano (St George's, University of London, UK) discuss the implications for treatment strategies. This three-part series provides comprehensive update on some of the most… View more

Heart Failure
The 2021 European Heart Failure Guidelines
Author(s): Nesan Shanmugam Added: 2 years ago

Heart Failure

Prevention & Chronic Conditions
New Challenges in the Management of Heart Failure - Meet the Experts
Author(s): Juan Carlos Kaski , Giuseppe Rosano , Alexander Lyon , et al Start date: Nov 04, 2020

Heart Failure
HFA 23 Late-Breaker Discussion: Hospital to Home in Heart Failure
Author(s): Harriette Van Spall , Tariq Ahmad , Jozine ter Maaten Added: 11 months ago
ESC-HFA 2023 —In this discussion, late-breaker host and principal investigator of PACT-HF, Dr Harriette Van Spall(McMaster University, CA) is joined by investigators Dr Jozine ter Maaten(The University Medical Center Groningen, NL) and Dr Tariq Ahmad(Yale School of Medicine, US). The focus of their conversation revolved around the latest data on the hospital-to-home transition in heart failure,… View more

Standards & Guidelines

Heart Failure
Non-pharmacological Management and Patient Education in HF Patients
Author(s): Tiny Jaarsma Added: 3 years ago
Heart failure (HF) has become a significant public health problem, with a rapidly rising incidence and prevalence that is predicted to continue to rise far into the 21st century.1 Overall, 1-2% of the adult population in developed countries worldwide suffers from HF but prevalence increases 10-fold in those over 75 years of age.2 Because the incidence of HF rises with age its prevalence will… View more

Heart Failure
ESC EORP HFA Heart Failure Long Term Registry
Author(s): Ovidiu Chioncel Added: 4 years ago
Prof Ovidiu Chioncel (University of Medicine Carol Davilla, Bucuresti, RO) discusses insights from theESC EORP HFA Heart Failure Long Term Registry –Acute heart failure congestion and perfusion status; impact of the clinical classification on in hospital and long-term outcomes. Filmed on site at HFA 2019 by Radcliffe Cardiology. Videographer: Mike Knight Interviewer: Liam O'Neill View more

Heart Failure